Kintor Pharmaceutical Limited (HKG:9939)

Kintor Pharmaceutical Statistics

Total Valuation

HKG:9939 has a market cap or net worth of HKD 1.38 billion. The enterprise value is 1.41 billion.

Market Cap	1.38B
Enterprise Value	1.41B

Important Dates

The next estimated earnings date is Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:9939 has 493.52 million shares outstanding. The number of shares has increased by 0.58% in one year.

Current Share Class	493.52M
Shares Outstanding	493.52M
Shares Change (YoY)	+0.58%
Shares Change (QoQ)	+0.71%
Owned by Insiders (%)	11.30%
Owned by Institutions (%)	0.22%
Float	382.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	114.40
PB Ratio	5.82
P/TBV Ratio	17.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.73
EV / Sales	117.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.07

Financial Position

The company has a current ratio of 0.44, with a Debt / Equity ratio of 0.40.

Current Ratio	0.44
Quick Ratio	0.42
Debt / Equity	0.40
Debt / EBITDA	n/a
Debt / FCF	-0.55
Interest Coverage	-24.74

Financial Efficiency

Return on equity (ROE) is -54.99% and return on invested capital (ROIC) is -20.86%.

Return on Equity (ROE)	-54.99%
Return on Assets (ROA)	-17.21%
Return on Invested Capital (ROIC)	-20.86%
Return on Capital Employed (ROCE)	-62.58%
Weighted Average Cost of Capital (WACC)	2.09%
Revenue Per Employee	88,500
Profits Per Employee	-1.35M
Employee Count	136
Asset Turnover	0.02
Inventory Turnover	6.52

Taxes

Income Tax	-303,531
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +190.53% in the last 52 weeks. The beta is -0.44, so HKG:9939's price volatility has been lower than the market average.

Beta (5Y)	-0.44
52-Week Price Change	+190.53%
50-Day Moving Average	2.33
200-Day Moving Average	2.06
Relative Strength Index (RSI)	60.25
Average Volume (20 Days)	3,736,114

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:9939 had revenue of HKD 12.04 million and -183.07 million in losses. Loss per share was -0.42.

Revenue	12.04M
Gross Profit	608,158
Operating Income	-170.73M
Pretax Income	-183.37M
Net Income	-183.07M
EBITDA	-150.14M
EBIT	-170.73M
Loss Per Share	-0.42

Balance Sheet

The company has 57.93 million in cash and 95.77 million in debt, with a net cash position of -37.84 million or -0.08 per share.

Cash & Cash Equivalents	57.93M
Total Debt	95.77M
Net Cash	-37.84M
Net Cash Per Share	-0.08
Equity (Book Value)	236.69M
Book Value Per Share	0.54
Working Capital	-87.21M

Cash Flow

In the last 12 months, operating cash flow was -173.07 million and capital expenditures -2.15 million, giving a free cash flow of -175.22 million.

Operating Cash Flow	-173.07M
Capital Expenditures	-2.15M
Free Cash Flow	-175.22M
FCF Per Share	-0.36

Margins

Gross Margin	5.05%
Operating Margin	-1,418.46%
Pretax Margin	-1,523.53%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:9939 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.58%
Shareholder Yield	-0.58%
Earnings Yield	-13.30%
FCF Yield	-12.73%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:9939 has an Altman Z-Score of -14.36 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-14.36
Piotroski F-Score	2